Fenwal Inc. inked a five-year agreement with Biolog-id to exclusively market, sell and distribute the Biolog-id RFID blood tracking and traceability system in Europe and the United States.

Biolog-id provides information about each blood unit following collection through transfusion with real-time data available to both the hospital and blood or plasma collection site. RFID labels can be read through containers and multiple labels can be read simultaneously.

The system aids in managing blood inventories, tracking temperature and storage conditions of each blood unit and assuring the right blood unit is matched to a patient need – helping to prevent transfusion errors by eliminating manual steps and paper-based procedures.

The system is already CE Marked in Europe, and the companies plan to submit it for clearance to the U.S. Food and Drug Administration.